Catabasis Pharmaceuticals Inc. (CATB) Rose 9.84% or 0.57 To Price $6.37 On Friday


Catabasis Pharmaceuticals Inc. (CATB) rose 9.84% or 0.57 to $6.37. It is approximately 434783 shares traded, which is 192.07% compare to the average total volume 226364. The market cap of CATB is $47.76 million. The year to date change is 40.77%. The 52 week price range is from $3.6 to $21.8. Price of CATB have changed 7.21% during last week. It have changed 30.04% over last month, -5.68% over last 3 months, -25.57% over last 6 months and -71.71% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CATB is 5.28. It is -17.11% below current price. The 200-day Moving Averages for CATB is 7.36. It is 15.54% above current price. The 52-week High is 21.8. It is 242.23% from the current price. The 52-week Low is 3.6. It is -43.49% from current price.

There are some statistics of CATB. It is has market cap $47.76 million. The share outstanding is 7.50 million. The average volume is 226364. The percent of top 15 Institution holding is 250.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CATB is -90.10%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CATB is -74.42%.


Tags:

Share this post